This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Kris Thiruvillakkat
Senior Director, Global Market Access Pipeline at CSL Behring
Speaker

Profile

Kris’s industry background span biopharma roles across Sales, Marketing, Commercial Operations and Market Access. For the last 12 yrs as a US and Global Market Access Professional, he has real world experiences solving for pricing, reimbursement and evidence gap challenges across various healthcare systems. Notably, Kris has enabled country team external engagements with Public and Private Payers as well as Health Technology Assessment agencies to maximize results. He also has business and scientific acumen within domain of specialty biopharmaceuticals for immunology, hematology, vaccinology, oncology, critical care and transplant medicine benefiting population health to rare disease communities.

Agenda Sessions

  • Pioneering Payer Partnerships – Crafting Value Stories That Resonate with Key Stakeholders

    4:00pm

At this event